Lido Advisors, LLC Tyme Technologies, Inc. Transaction History

Lido Advisors, LLC

  • $17.8 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$0.6 - $1.04 $14,770 - $25,601
-24,617 Closed
0 $0
Q3 2021

Feb 15, 2022
BUY
$0.99 - $1.38 $7,504 - $10,460
7,580 Added 44.49%
24,617 $25,000
Q3 2021

Nov 12, 2021
SELL
$0.99 - $1.38 $7,504 - $10,460
-7,580 Reduced 30.79%
17,037 $25,000
Q1 2021

May 13, 2021
BUY
$1.34 - $3.53 $4,124 - $10,865
3,078 Added 14.29%
24,617 $44,000
Q2 2020

Aug 12, 2020
BUY
$0.97 - $1.7 $20,892 - $36,616
21,539 New
21,539 $29,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email